MedicQuant, a spin-out company from iNANO and Department of Chemistry, has been granted one of the newly awarded AU Launch grants. MedicQuant is headed by former PhD students and post docs at iNANO, Line Debois Frejlev Nielsen and Malthe Hansen-Bruhn, and they receive DKK 197,000 from the entrepreneurial grant AU Launch for business development.

Despite numerous trials in the past decade prostate tumors have so far resisted treatment with immunotherapy. Now iNANO and Aarhus University Hospital researchers join forces to move prostate cancer immunotherapies closer to the clinic by using Albumin-fused T-cell engagers as a potential immunotherapy tailored to selected prostate cancer patients.

Danish researchers have determined the three-dimensional structure of the proteolytic enzyme PAPP-A. The results may allow us to better understand the basic biology that regulates linear growth of vertebrates. The same regulatory mechanisms are also involved in several age-related diseases, and thus, the research is an important step towards the development of novel types of drugs.